CN1328827A - Nanometer silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process - Google Patents
Nanometer silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process Download PDFInfo
- Publication number
- CN1328827A CN1328827A CN01129507A CN01129507A CN1328827A CN 1328827 A CN1328827 A CN 1328827A CN 01129507 A CN01129507 A CN 01129507A CN 01129507 A CN01129507 A CN 01129507A CN 1328827 A CN1328827 A CN 1328827A
- Authority
- CN
- China
- Prior art keywords
- silver
- nano
- prostatitis
- gel
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 201000007094 prostatitis Diseases 0.000 title claims abstract description 25
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 10
- 239000004332 silver Substances 0.000 title claims abstract description 10
- 238000009776 industrial production Methods 0.000 title claims description 6
- 206010061218 Inflammation Diseases 0.000 title abstract description 3
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 239000000654 additive Substances 0.000 claims abstract description 7
- 208000014617 hemorrhoid Diseases 0.000 claims abstract description 7
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000002344 surface layer Substances 0.000 claims abstract description 4
- 229910001923 silver oxide Inorganic materials 0.000 claims abstract description 3
- 230000003115 biocidal effect Effects 0.000 claims abstract 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 36
- 230000000844 anti-bacterial effect Effects 0.000 claims description 29
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 20
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 17
- 229920001223 polyethylene glycol Polymers 0.000 claims description 16
- 239000002202 Polyethylene glycol Substances 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 13
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 13
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002270 dispersing agent Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 5
- 239000000178 monomer Substances 0.000 claims description 5
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 5
- 230000002744 anti-aggregatory effect Effects 0.000 claims description 4
- 239000003623 enhancer Substances 0.000 claims description 4
- 229920005615 natural polymer Polymers 0.000 claims description 4
- 229920001059 synthetic polymer Polymers 0.000 claims description 4
- 239000002563 ionic surfactant Substances 0.000 claims description 3
- 239000002736 nonionic surfactant Substances 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 208000017497 prostate disease Diseases 0.000 claims description 3
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 claims description 2
- 229920003051 synthetic elastomer Polymers 0.000 claims 1
- 230000000996 additive effect Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 description 25
- 230000000694 effects Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 238000002156 mixing Methods 0.000 description 7
- 238000005406 washing Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000013329 compounding Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 206010041925 Staphylococcal infections Diseases 0.000 description 3
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000588914 Enterobacter Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000607265 Vibrio vulnificus Species 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229940124350 antibacterial drug Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 241000607522 Aeromonas sobria Species 0.000 description 1
- 241000588813 Alcaligenes faecalis Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 244000255890 Biophytum sensitivum Species 0.000 description 1
- 241000222173 Candida parapsilosis Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589614 Pseudomonas stutzeri Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 229940005347 alcaligenes faecalis Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- -1 benzene azole nitrogen benzyl cephalosporin Chemical class 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000032343 candida glabrata infection Diseases 0.000 description 1
- 229940055022 candida parapsilosis Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960001967 tacrolimus Drugs 0.000 description 1
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
- A61L2/238—Metals or alloys, e.g. oligodynamic metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
Abstract
Description
Claims (10)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011107677A CN1179646C (en) | 2001-04-20 | 2001-04-20 | Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process |
CN01223000U CN2479952Y (en) | 2001-04-20 | 2001-05-08 | Nm silver plaster for trauma |
CN01129505A CN1328819A (en) | 2001-04-20 | 2001-06-22 | Nanometer silver antimicrobial inflammation-relieving film for curing gynecopathy and its production process |
CNB011295074A CN1169529C (en) | 2001-04-20 | 2001-06-22 | Nanometer silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process |
CNB018231578A CN1224479C (en) | 2001-04-20 | 2001-11-26 | Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod and its application |
PCT/CN2001/001584 WO2002090025A1 (en) | 2001-04-20 | 2001-11-26 | Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod and its application |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011107677A CN1179646C (en) | 2001-04-20 | 2001-04-20 | Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process |
CN01223000U CN2479952Y (en) | 2001-04-20 | 2001-05-08 | Nm silver plaster for trauma |
CN01129505A CN1328819A (en) | 2001-04-20 | 2001-06-22 | Nanometer silver antimicrobial inflammation-relieving film for curing gynecopathy and its production process |
CNB011295074A CN1169529C (en) | 2001-04-20 | 2001-06-22 | Nanometer silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1328827A true CN1328827A (en) | 2002-01-02 |
CN1169529C CN1169529C (en) | 2004-10-06 |
Family
ID=27429906
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011107677A Expired - Fee Related CN1179646C (en) | 2001-04-20 | 2001-04-20 | Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process |
CN01223000U Expired - Lifetime CN2479952Y (en) | 2001-04-20 | 2001-05-08 | Nm silver plaster for trauma |
CNB011295074A Expired - Fee Related CN1169529C (en) | 2001-04-20 | 2001-06-22 | Nanometer silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process |
CN01129505A Pending CN1328819A (en) | 2001-04-20 | 2001-06-22 | Nanometer silver antimicrobial inflammation-relieving film for curing gynecopathy and its production process |
CNB018231578A Expired - Fee Related CN1224479C (en) | 2001-04-20 | 2001-11-26 | Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod and its application |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011107677A Expired - Fee Related CN1179646C (en) | 2001-04-20 | 2001-04-20 | Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process |
CN01223000U Expired - Lifetime CN2479952Y (en) | 2001-04-20 | 2001-05-08 | Nm silver plaster for trauma |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN01129505A Pending CN1328819A (en) | 2001-04-20 | 2001-06-22 | Nanometer silver antimicrobial inflammation-relieving film for curing gynecopathy and its production process |
CNB018231578A Expired - Fee Related CN1224479C (en) | 2001-04-20 | 2001-11-26 | Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod and its application |
Country Status (2)
Country | Link |
---|---|
CN (5) | CN1179646C (en) |
WO (1) | WO2002090025A1 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6692773B2 (en) | 2000-07-27 | 2004-02-17 | Nucryst Pharmaceuticals Corp. | Treatment of hyperproliferative skin disorders and diseases |
US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
US6723350B2 (en) | 2001-04-23 | 2004-04-20 | Nucryst Pharmaceuticals Corp. | Lubricious coatings for substrates |
US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
WO2007017901A2 (en) * | 2005-06-08 | 2007-02-15 | Khandelwal Sanjeev | Silver nanoparticle dispersion formulation |
US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
US7470437B2 (en) | 2000-07-27 | 2008-12-30 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions with a metal-containing material |
US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
CN105640986A (en) * | 2014-11-28 | 2016-06-08 | 广东工业大学 | Silver nanoparticle composition for control of lung cancer and prostate cancer |
CN113664213A (en) * | 2021-08-04 | 2021-11-19 | 湖南伟方生命科技有限公司 | Preparation method and application of nano-silver antibacterial liquid |
CN114028318A (en) * | 2021-10-14 | 2022-02-11 | 湖南伟方生命科技有限公司 | Male antibacterial liquid and preparation method and application thereof |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1627901A (en) * | 2002-06-03 | 2005-06-15 | 深圳市清华源兴生物医药科技有限公司 | Nano composite material of silver |
DE10346387A1 (en) * | 2003-10-07 | 2005-06-09 | Henkel Kgaa | Antimicrobial equipment of bathroom and toilet articles |
EP1616926A1 (en) | 2004-07-15 | 2006-01-18 | Interuniversitair Microelektronica Centrum ( Imec) | Slurry composition and method for chemical polishing of copper integrated with tungsten based barrier metals |
US8399027B2 (en) | 2005-04-14 | 2013-03-19 | 3M Innovative Properties Company | Silver coatings and methods of manufacture |
CN100386369C (en) * | 2005-06-03 | 2008-05-07 | 陈汝霖 | New type products of Nano silver latex, and preparation method |
US20070166399A1 (en) | 2006-01-13 | 2007-07-19 | 3M Innovative Properties Company | Silver-containing antimicrobial articles and methods of manufacture |
US20090232792A1 (en) * | 2006-06-16 | 2009-09-17 | Valerie Bicard-Benhamou | Antimicrobial carbon |
CN100457084C (en) * | 2006-08-04 | 2009-02-04 | 武汉正午阳光医药生物科技有限公司 | Nanometer silver type external use antibiotic gel for female external use and its prepn. method |
CN100396290C (en) * | 2006-11-03 | 2008-06-25 | 段炬红 | External use anti-bacteria foaming agent for gynecology |
CN101049279B (en) * | 2007-04-30 | 2010-06-23 | 东莞市拓扑光电科技有限公司 | Antibacterial shampoo of Nano silver, and preparation method |
US8815307B2 (en) * | 2008-12-31 | 2014-08-26 | Colotex Industrial Co., Ltd. | Process for producing porous polymer masterbatch and fiber thereof having anti-bacterial and odor eliminating functions |
CN102430761A (en) * | 2011-12-12 | 2012-05-02 | 池州学院 | Preparation method for water-soluble nano silver for killing oncomelania hupensis |
CN103341642B (en) * | 2013-07-26 | 2015-12-02 | 莆田学院 | A kind of cellulose green syt method of nano silver particles |
CN103688996B (en) * | 2013-11-28 | 2014-12-10 | 太原理工大学 | Method for preparing silver-loaded antibacterial agent by using waste cotton fiber |
CN107598186B (en) * | 2017-08-30 | 2019-08-20 | 苏州工业园区格云环保新材料有限公司 | A kind of preparation method of nano silver and its fumigation liquid |
CN109137490A (en) * | 2018-06-27 | 2019-01-04 | 苏州市天翱特种织绣有限公司 | A kind of antibacterial modified method of cotton fiber |
EP3920726A1 (en) * | 2019-02-05 | 2021-12-15 | Griffith Foods International Inc. | Anti-caking agent or flow agent for a seasoning, pharmaceuticals or nutraceuticals |
CN111763365B (en) * | 2020-07-17 | 2022-09-02 | 安信纳米生物科技(珠海)有限公司 | Antibacterial fresh-keeping material containing nano-silver and preparation method thereof |
CN115137681A (en) * | 2022-06-23 | 2022-10-04 | 深圳市黄田荔枝品牌发展有限公司 | Litchi mask and preparation method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07173022A (en) * | 1993-12-17 | 1995-07-11 | Asahi Chem Ind Co Ltd | Antimicrobial agent |
CN1058868C (en) * | 1994-11-26 | 2000-11-29 | 广州安信生物科技发展有限公司 | Long-effect and broad-spectrum antibiotic granules and its production |
JP4025839B2 (en) * | 1996-09-12 | 2007-12-26 | Dowaエレクトロニクス株式会社 | Silver powder and method for producing silver powder |
CN1161511C (en) * | 1999-07-27 | 2004-08-11 | 蒋建华 | Long-acting wide-spectrum antiseptic nanometer silver fabric and its making method |
CN1266761A (en) * | 2000-03-23 | 2000-09-20 | 南京大学 | Process for preparing nm-class silver powder |
-
2001
- 2001-04-20 CN CNB011107677A patent/CN1179646C/en not_active Expired - Fee Related
- 2001-05-08 CN CN01223000U patent/CN2479952Y/en not_active Expired - Lifetime
- 2001-06-22 CN CNB011295074A patent/CN1169529C/en not_active Expired - Fee Related
- 2001-06-22 CN CN01129505A patent/CN1328819A/en active Pending
- 2001-11-26 CN CNB018231578A patent/CN1224479C/en not_active Expired - Fee Related
- 2001-11-26 WO PCT/CN2001/001584 patent/WO2002090025A1/en not_active Application Discontinuation
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
US7470437B2 (en) | 2000-07-27 | 2008-12-30 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions with a metal-containing material |
US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
US6692773B2 (en) | 2000-07-27 | 2004-02-17 | Nucryst Pharmaceuticals Corp. | Treatment of hyperproliferative skin disorders and diseases |
US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
US6939568B2 (en) | 2001-04-23 | 2005-09-06 | Nucryst Pharmaceuticals Corp. | Treatment of inflammatory skin conditions |
US6723350B2 (en) | 2001-04-23 | 2004-04-20 | Nucryst Pharmaceuticals Corp. | Lubricious coatings for substrates |
US6989156B2 (en) | 2001-04-23 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
US7087249B2 (en) | 2001-04-23 | 2006-08-08 | Nucryst Pharmaceuticals Corp. | Treatment of mucosal membranes |
US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
WO2007017901A3 (en) * | 2005-06-08 | 2007-06-14 | Khandelwal Sanjeev | Silver nanoparticle dispersion formulation |
WO2007017901A2 (en) * | 2005-06-08 | 2007-02-15 | Khandelwal Sanjeev | Silver nanoparticle dispersion formulation |
US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
CN105640986A (en) * | 2014-11-28 | 2016-06-08 | 广东工业大学 | Silver nanoparticle composition for control of lung cancer and prostate cancer |
CN113664213A (en) * | 2021-08-04 | 2021-11-19 | 湖南伟方生命科技有限公司 | Preparation method and application of nano-silver antibacterial liquid |
CN114028318A (en) * | 2021-10-14 | 2022-02-11 | 湖南伟方生命科技有限公司 | Male antibacterial liquid and preparation method and application thereof |
CN114028318B (en) * | 2021-10-14 | 2023-11-21 | 湖南伟方生命科技有限公司 | Male antibacterial liquid and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN2479952Y (en) | 2002-03-06 |
CN1322474A (en) | 2001-11-21 |
CN1169529C (en) | 2004-10-06 |
CN1224479C (en) | 2005-10-26 |
WO2002090025A1 (en) | 2002-11-14 |
CN1179646C (en) | 2004-12-15 |
CN1328819A (en) | 2002-01-02 |
CN1505551A (en) | 2004-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1328827A (en) | Nanometer silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process | |
Ran et al. | Hyaluronic acid-templated Ag nanoparticles/graphene oxide composites for synergistic therapy of bacteria infection | |
El-Ela et al. | New approach in ulcer prevention and wound healing treatment using doxycycline and amoxicillin/LDH Nanocomposites | |
CN1161511C (en) | Long-acting wide-spectrum antiseptic nanometer silver fabric and its making method | |
CN101999412A (en) | Nano-silver solution and preparation method thereof | |
CN1147640C (en) | Antibacterial fabric containing nm-class silver powder and its making method | |
Sun et al. | Phytochemical-encapsulated nanoplatform for “on-demand” synergistic treatment of multidrug-resistant bacteria | |
AU2001240358A1 (en) | Bactericidal preparation | |
CN1183285C (en) | Aggregation-preventing wide-spectrum nanometer antibiotic silver yarn and its industrial production process | |
CN1672689A (en) | Nano silver antiseptic gel for treating women's genital tract infection and its prepn and application | |
CN1369206A (en) | Nano Silver sterilizing gel, its preparing method and use | |
CN1843124A (en) | Nano silver coating agent for sterilization and its preparation method | |
CN1943593A (en) | External use anti-bacteria foaming agent for gynecology | |
Samrat et al. | Evaluation of improved antifungal activity of fluconazole–silver nanoconjugate against pathogenic fungi | |
CN1569366A (en) | Nano-silver aqueous solution preparation and its preparation method, use and using method | |
Islamov et al. | New antituberculosis drug FS-1 | |
CN1259919C (en) | Sterilizing and bacteria inhibiting pharmaceutical composition and its formulation and preparation process | |
CN1206990C (en) | Liquid preparation containing norfloxacin and metronidazole | |
CN1307881C (en) | New use of bactericide H4Ag 206 containing silver and its prepared medicine | |
CN103110976A (en) | Skin antimicrobial gel recipe and preparation method thereof | |
CN105380900B (en) | A kind of nano magnetic therapy external-use gel for treating acne and its preparation method and application | |
CN1335426A (en) | Aggregation-preventing wide-spectrum antiseptic nanometer silver knitted article and fabric and their industrial production process | |
CN1286525C (en) | New type pellicle of ocean lysozyme and preparation method | |
US11883542B1 (en) | Chitosan film with ternary metal oxides | |
US11969510B1 (en) | Chitosan film with ternary metal oxides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: ZHU LI Effective date: 20050225 Owner name: TSINGHUA YUANXING BIO-PHARM TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHU HONGJUN |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20050225 Address after: 518057, Shenzhen hi tech Development Zone, North District, Nanshan District Road Patentee after: Tsinghua Yuanxing Biomedicine Tech Co., Ltd., Shenzhen Address before: Changning District Shanghai Fahuazhen 200000 No. 236 Co-patentee before: Zhu Chi Patentee before: Zhu Hongjun |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Wang Lingjiang Document name: Special business review memo |
|
C56 | Change in the name or address of the patentee |
Owner name: SHENZHEN YUANXING BIO-PHARM CO., LTD. Free format text: FORMER NAME: TSINGHUA YUANXING BIOMEDICINE TECH CO., LTD., SHENZHEN |
|
CP03 | Change of name, title or address |
Address after: 518057 Lang Shan Road, North District, Nanshan District hi tech Development Zone, Guangdong, Shenzhen Patentee after: Shenzhen Yuanxing Bio-Pharm Co., Ltd. Address before: 518057, Shenzhen hi tech Development Zone, North District, Nanshan District Road Patentee before: Tsinghua Yuanxing Biomedicine Tech Co., Ltd., Shenzhen |
|
DD01 | Delivery of document by public notice |
Addressee: Wang Lingjiang Document name: Notification of Passing Examination on Formalities |
|
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN YUANXING NANO-PHARMA CO.,LTD. Free format text: FORMER OWNER: SHENZHEN YUANXING BIO-PHARM CO., LTD. Effective date: 20150909 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150909 Address after: 518000 Guangdong city of Shenzhen province Nanshan District high tech Industrial Park, North Central Avenue, North Song Ping Road No. 1 Lite technology building south 10 layer 1001 Patentee after: Shenzhen Yuanxing Nano-Pharmaceutical Co., Ltd. Address before: 518057 Lang Shan Road, North District, Nanshan District hi tech Development Zone, Guangdong, Shenzhen Patentee before: Shenzhen Yuanxing Bio-Pharm Co., Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Wang Lingjiang Document name: Notification of Passing Examination on Formalities |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041006 Termination date: 20160622 |